Dr. Behler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Webster St Ste 225
San Francisco, CA 94115Phone+1 415-923-3012Fax+1 415-928-4840
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2004 - 2007
- University of California (San Francisco)Residency, Internal Medicine, 2001 - 2004
- University of Washington School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Excellence in Teaching Award Haile T. Debas Academy of Medical Educators, University of California, San Francisco, 2010
- Junior Inductee Alpha Omega Alpha, 2000
- Junior Inductee Phi Beta Kappa, 1993
Clinical Trials
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant Start of enrollment: 2007 May 01
- Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 168 citationsBrentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura
Blood. 2018-07-05 - 25 citationsThree‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphomaAnn S. LaCasce, R. Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura
British Journal of Haematology. 2020-02-12 - 94 citationsImmunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRIMatthew J. Wieduwilt, Francisco Valles, Samar Issa, Caroline Behler, Jimmy Hwang
Clinical Cancer Research. 2012-02-15
Professional Memberships
- Member
- Member
External Links
- Pacific Hematology Oncology Associateshttp://phoamd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: